On the public citation graph

The cost-effectiveness of systematic screening for age-related macular degeneration in South Korea

https://doi.org/10.1371/journal.pone.0206690
0 signed · 63 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1001/archopht.117.10.1329openalex-snapshot
Photodynamic Therapy of Subfoveal Choroidal Neovascularization in Age-related Macular Degeneration With Verteporfin
inferredcites →https://doi.org/10.1001/archopht.118.1.47openalex-snapshot
Utility Values and Age-related Macular Degeneration
inferredcites →https://doi.org/10.1001/archopht.119.10.1439openalex-snapshot
A Randomized, Placebo-Controlled, Clinical Trial of High-Dose Supplementation With Vitamins C and E and Beta Carotene for Age-Related Cataract and Vision Loss
inferredcites →https://doi.org/10.1001/archopht.122.4.564openalex-snapshot
Prevalence of Age-Related Macular Degeneration in the United States
inferredcites →https://doi.org/10.1001/archopht.124.12.1754openalex-snapshot
The Economic Burden of Major Adult Visual Disorders in the United States
inferredcites →https://doi.org/10.1002/14651858.cd011230openalex-snapshot
Systemic safety of bevacizumab versus ranibizumab for neovascular age-related macular degeneration
inferredcites →https://doi.org/10.1002/14651858.cd011230.pub2openalex-snapshot
Systemic safety of bevacizumab versus ranibizumab for neovascular age-related macular degeneration
inferredcites →https://doi.org/10.1007/s00417-014-2641-3openalex-snapshot
The cost-utility of aflibercept for the treatment of age-related macular degeneration compared to bevacizumab and ranibizumab and the influence of model parameters
inferredcites →https://doi.org/10.1007/s11892-012-0285-4openalex-snapshot
Screening for Diabetic Retinopathy and Diabetic Macular Edema in the United Kingdom
inferredcites →https://doi.org/10.1016/j.ajo.2003.11.023openalex-snapshot
Photodynamic therapy for age-related macular degeneration: a candid appraisal
inferredcites →https://doi.org/10.1016/j.ijcard.2007.04.114openalex-snapshot
Antihypertensive drug medication adherence and its affecting factors in South Korea
inferredcites →https://doi.org/10.1016/j.jval.2017.04.015openalex-snapshot
Cost-Utility Analysis of Extending Public Health Insurance Coverage to Include Diabetic Retinopathy Screening by Optometrists
inferredcites →https://doi.org/10.1016/j.ophtha.2007.03.008openalex-snapshot
The Natural History and Prognosis of Neovascular Age-Related Macular Degeneration
inferredcites →https://doi.org/10.1016/j.ophtha.2012.03.053openalex-snapshot
Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration
inferredcites →https://doi.org/10.1016/j.ophtha.2013.03.046openalex-snapshot
Seven-Year Outcomes in Ranibizumab-Treated Patients in ANCHOR, MARINA, and HORIZON
inferredcites →https://doi.org/10.1016/j.ophtha.2014.04.040openalex-snapshot
Cigarette Smoking and the Natural History of Age-Related Macular Degeneration
inferredcites →https://doi.org/10.1016/j.ophtha.2015.06.050openalex-snapshot
Cost-Effectiveness of Screening for Intermediate Age-Related Macular Degeneration during Diabetic Retinopathy Screening
inferredcites →https://doi.org/10.1016/s0002-9394(01)00967-9openalex-snapshot
Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization—verteporfin in photodynamic therapy report 2
inferredcites →https://doi.org/10.1016/s0002-9394(01)01237-5openalex-snapshot
Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization—verteporfin in photodynamic therapy report 2
inferredcites →https://doi.org/10.1016/s0002-9394(02)01522-2openalex-snapshot
The sensitivity and specificity of single-field nonmydriatic monochromatic digital fundus photography with remote image interpretation for diabetic retinopathy screening: a comparison with ophthalmoscopy and standardized mydriatic color photography
inferredcites →https://doi.org/10.1016/s0008-4182(00)80077-0openalex-snapshot
Converting visual acuity to utilities
inferredcites →https://doi.org/10.1016/s0161-6420(00)00635-7openalex-snapshot
Quality of life associated with unilateral and bilateral good vision
inferredcites →https://doi.org/10.1016/s2214-109x(13)70145-1openalex-snapshot
Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis
inferredcites →https://doi.org/10.1038/sj.eye.6701916openalex-snapshot
Screening for age-related macular degeneration using nonstereo digital fundus photographs
inferredcites →https://doi.org/10.1038/sj.eye.6702565openalex-snapshot
AMD: Should we screen?
inferredcites →https://doi.org/10.1046/j.1442-9071.2000.00296.xopenalex-snapshot
Direct costs of blindness in Australia
inferredcites →https://doi.org/10.1046/j.1442-9071.2000.00315.xopenalex-snapshot
Age‐specific prevalence and causes of bilateral and unilateral visual impairment in older Australians: the Blue Mountains Eye Study
inferredcites →https://doi.org/10.1056/nejmoa054481openalex-snapshot
Ranibizumab for Neovascular Age-Related Macular Degeneration
inferredcites →https://doi.org/10.1056/nejmoa062655openalex-snapshot
Ranibizumab versus Verteporfin for Neovascular Age-Related Macular Degeneration
inferredcites →https://doi.org/10.1056/nejmoa1102673openalex-snapshot
Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration
inferredcites →https://doi.org/10.1056/nejmra0801537openalex-snapshot
Age-Related Macular Degeneration
inferredcites →https://doi.org/10.1076/opep.11.2.67.28158openalex-snapshot
2002 Global update of available data on visual impairment: a compilation of population-based prevalence studies
inferredcites →https://doi.org/10.1097/01.icu.0000193079.55240.18openalex-snapshot
Recent developments in understanding the pathophysiology of elevated intraocular pressure.
inferredcites →https://doi.org/10.1097/iae.0b013e318050d2ecopenalex-snapshot
THE SIGNIFICANCE OF EARLY DETECTION OF AGE-RELATED MACULAR DEGENERATION
inferredcites →https://doi.org/10.1111/j.1365-2753.2010.01546.xopenalex-snapshot
Cost‐utility analysis of bevacizumab versus ranibizumab in neovascular age‐related macular degeneration using a Markov model
inferredcites →https://doi.org/10.1136/bjo.2003.023986openalex-snapshot
Cost effectiveness of photodynamic therapy with verteporfin for age related macular degeneration: the UK case
inferredcites →https://doi.org/10.1136/bjo.85.2.173openalex-snapshot
Transpupillary thermotherapy (TTT) for the treatment of choroidal neovascularisation
inferredcites →https://doi.org/10.1136/bjophthalmol-2013-304338openalex-snapshot
Improving the cost-effectiveness of photographic screening for diabetic macular oedema: a prospective, multi-centre, UK study
inferredcites →https://doi.org/10.1136/bjophthalmol-2014-305149openalex-snapshot
Efficacy and adverse events of aflibercept, ranibizumab and bevacizumab in age-related macular degeneration: a trade-off analysis
inferredcites →https://doi.org/10.1371/journal.pone.0133628openalex-snapshot
The Clinical Effectiveness and Cost-Effectiveness of Screening for Age-Related Macular Degeneration in Japan: A Markov Modeling Study
inferredcites →https://doi.org/10.1517/14712598.2015.1057565openalex-snapshot
Ranibizumab and aflibercept for the treatment of wet age-related macular degeneration
inferredcites →https://doi.org/10.2165/00019053-200826010-00006openalex-snapshot
Economic Burden of Bilateral Neovascular Age-Related Macular Degeneration
inferredcites →https://doi.org/10.2307/3350062openalex-snapshot
Federal Budgetary Costs of Blindness
inferredcites →https://doi.org/10.3109/02713683.2014.907431openalex-snapshot
Prevalence and Risk Factors for Age-Related Macular Degeneration: Korean National Health and Nutrition Examination Survey 2008–2011
inferredcites →https://doi.org/10.3310/hta7090openalex-snapshot
Clinical effectiveness and cost-utility of photodynamic therapy for wet age-related macular degeneration: a systematic review and economic evaluation

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.3968904openalex-extracted
inferred← citeshttps://doi.org/10.1007/978-3-030-78601-4_3openalex-snapshot
Overview of Artificial Intelligence Systems in Ophthalmology
inferred← citeshttps://doi.org/10.1007/s00347-025-02250-6openalex-snapshot
Screeningempfehlungen für Glaukom, altersabhängige Makuladegeneration und diabetische Augenerkrankungen
inferred← citeshttps://doi.org/10.1007/s10384-021-00890-0openalex-snapshot
Real-world effectiveness of screening programs for age-related macular degeneration: amended Japanese specific health checkups and augmented screening programs with OCT or AI
inferred← citeshttps://doi.org/10.1007/s11517-024-03160-6openalex-snapshot
ConKeD: multiview contrastive descriptor learning for keypoint-based retinal image registration
inferred← citeshttps://doi.org/10.1016/j.lanwpc.2022.100435openalex-snapshot
Cost-effectiveness and cost-utility of traditional and telemedicine combined population-based age-related macular degeneration and diabetic retinopathy screening in rural and urban China
inferred← citeshttps://doi.org/10.1016/j.lanwpc.2022.100476openalex-snapshot
Digital health in medicine: Important considerations in evaluating health economic analysis
inferred← citeshttps://doi.org/10.1038/s41572-021-00265-2openalex-snapshot
Age-related macular degeneration
inferred← citeshttps://doi.org/10.1080/08164622.2021.2022961openalex-snapshot
A clinical perspective on the expanding role of artificial intelligence in age-related macular degeneration
inferred← citeshttps://doi.org/10.1097/apo.0000000000000403openalex-snapshot
Economic Evaluations of Artificial Intelligence in Ophthalmology
inferred← citeshttps://doi.org/10.1186/s12889-024-17796-4openalex-snapshot
Prevalence of eye and adnexal disorders among elderly inmates in Taiwan prisons
inferred← citeshttps://doi.org/10.1186/s12938-024-01222-2openalex-snapshot
Evaluating imaging repeatability of fully self-service fundus photography within a community-based eye disease screening setting
inferred← citeshttps://doi.org/10.1371/journal.pone.0207736openalex-snapshot
Correction: The cost-effectiveness of systematic screening for age-related macular degeneration in South Korea
inferred← citeshttps://doi.org/10.1371/journal.pone.0209521openalex-snapshot
Correction: The cost-effectiveness of systematic screening for age-related macular degeneration in South Korea
inferred← citeshttps://doi.org/10.3390/nu14030401openalex-snapshot
Protective Effects of Spirulina maxima against Blue Light-Induced Retinal Damages in A2E-Laden ARPE-19 Cells and Balb/c Mice
inferred← citeshttps://doi.org/10.6084/m9.figshare.26692414openalex-snapshot
Additional file 2 of Evaluating imaging repeatability of fully self-service fundus photography within a community-based eye disease screening setting
inferred← citeshttps://doi.org/10.6084/m9.figshare.26692417openalex-snapshot
Additional file 3 of Evaluating imaging repeatability of fully self-service fundus photography within a community-based eye disease screening setting
inferred← citeshttps://doi.org/10.6084/m9.figshare.26692420openalex-snapshot
Additional file 4 of Evaluating imaging repeatability of fully self-service fundus photography within a community-based eye disease screening setting
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.